| STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma F Skoulidis, ME Goldberg, DM Greenawalt, MD Hellmann, MM Awad, ... Cancer discovery 8 (7), 822-835, 2018 | 1282 | 2018 |
| A novel next-generation sequencing approach to detecting microsatellite instability and pan-tumor characterization of 1000 microsatellite instability–high cases in 67,000 … SE Trabucco, K Gowen, SL Maund, E Sanford, DA Fabrizio, MJ Hall, ... The Journal of Molecular Diagnostics 21 (6), 1053-1066, 2019 | 182 | 2019 |
| Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma SE Trabucco, RM Gerstein, AM Evens, JE Bradner, LD Shultz, DL Greiner, ... Clinical cancer research 21 (1), 113-122, 2015 | 162 | 2015 |
| Oxidative stress, mitochondrial dysfunction and the mitochondria theory of aging Y Kong, SE Trabucco, H Zhang Aging 39, 86-107, 2014 | 126 | 2014 |
| Actionable activating Oncogenic ERBB2/HER2 transmembrane and juxtamembrane domain Mutations KB Pahuja, TT Nguyen, BS Jaiswal, K Prabhash, TM Thaker, K Senger, ... Cancer cell 34 (5), 792-806. e5, 2018 | 121 | 2018 |
| Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer RJ Hartmaier, SE Trabucco, N Priedigkeit, JH Chung, CA Parachoniak, ... Annals of Oncology 29 (4), 872-880, 2018 | 107 | 2018 |
| Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma MM Gounder, NP Agaram, SE Trabucco, V Robinson, RA Ferraro, ... Nature communications 13 (1), 3406, 2022 | 75 | 2022 |
| Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients TM Fernando, R Piskol, R Bainer, ES Sokol, SE Trabucco, Q Zhang, ... Nature communications 11 (1), 5551, 2020 | 75 | 2020 |
| A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis NQ Bui, J Przybyl, SE Trabucco, G Frampton, T Hastie, M van de Rijn, ... Clinical Sarcoma Research 9, 1-11, 2019 | 67 | 2019 |
| BRAF in Lung Cancers: Analysis of Patient Cases Reveals Recurrent BRAF Mutations, Fusions, Kinase Duplications, and Concurrent Alterations Y Sheikine, D Pavlick, SJ Klempner, SE Trabucco, JH Chung, ... JCO Precision Oncology 2, 1-15, 2018 | 46 | 2018 |
| The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors J Rinaldi, ES Sokol, RJ Hartmaier, SE Trabucco, GM Frampton, ... PloS one 15 (5), e0231999, 2020 | 40 | 2020 |
| Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay AM Intlekofer, E Joffe, CL Batlevi, P Hilden, J He, VE Seshan, AD Zelenetz, ... Blood Cancer Journal 8 (6), 60, 2018 | 32 | 2018 |
| STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma. Cancer Discov. 2018; 8 (7): 822–835. doi: 10.1158/2159-8290 F Skoulidis, ME Goldberg, DM Greenawalt, MD Hellmann, MM Awad, ... CD-18-0099, 0 | 27 | |
| PARP Inhibitor Insensitivity to BRCA1/2 Monoallelic Mutations in Microsatellite Instability-High Cancers ES Sokol, DX Jin, A Fine, SE Trabucco, S Maund, G Frampton, L Molinero, ... JCO Precision Oncology 6, e2100531, 2022 | 21 | 2022 |
| Smurf2 regulates hematopoietic stem cell self‐renewal and aging C Ramkumar, Y Kong, SE Trabucco, RM Gerstein, H Zhang Aging cell 13 (3), 478-486, 2014 | 20 | 2014 |
| The Pan‐Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA U Disel, R Madison, K Abhishek, JH Chung, SE Trabucco, AO Matos, ... The oncologist 25 (1), e39-e47, 2020 | 19 | 2020 |
| YY1 regulates the germinal center reaction by inhibiting apoptosis SE Trabucco, RM Gerstein, H Zhang The Journal of Immunology 197 (5), 1699-1707, 2016 | 19 | 2016 |
| Clinicopathologic, genomic and protein expression characterization of 356 ROS1 fusion driven solid tumors cases RSP Huang, J Haberberger, E Sokol, AB Schrock, N Danziger, R Madison, ... International Journal of Cancer 148 (7), 1778-1788, 2021 | 14 | 2021 |
| Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors JW Riess, S Rahman, W Kian, C Edgerly, AM Heilmann, R Madison, ... Translational Oncology 14 (10), 101184, 2021 | 12 | 2021 |
| Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers KE Hutchinson, JW Chen, HM Savage, TJ Stout, F Schimmoller, J Cortés, ... Genome Medicine 15 (1), 28, 2023 | 9 | 2023 |
